New Insurance Law Grants Right to be Forgotten for Cancer Survivors

For thousands of individuals across Ireland who have successfully battled cancer, the journey to homeownership has long been obstructed by a secondary, bureaucratic hurdle. Securing mortgage protection insurance, a mandatory requirement for drawing down a residential mortgage under Irish law, has historically meant facing exorbitant premiums or outright refusals based on past medical history. The recently published Insurance (Disregard of Certain Medical History and Miscellaneous Provisions) Act 2026 aims to dismantle this barrier once and for all. Signed into law by the President on the fifteenth of July 2026, this landmark legislation introduces a statutory right to be forgotten for cancer survivors seeking to purchase their principal private residence. Although the Act is awaiting its official commencement order, its publication marks a transformative moment for consumer rights and medical equality within the Irish state.

From Private Members Bill to Government Legislation

The legislative journey of this crucial reform highlights a growing recognition within the Oireachtas of the unfair financial penalties borne by those who have recovered from serious illness. Originally introduced as a private members bill by Catherine Ardagh TD, the proposed legislation was widely referred to as the 'Right to be Forgotten' bill. Its core premise resonated strongly across the political spectrum, leading to its formal adoption and progression by the Government. This development aligns Ireland with a broader European movement aimed at ensuring that individuals are not perpetually defined by their medical past when engaging with financial services. By elevating this initiative to government-backed legislation, the State has acknowledged that outdated actuarial models must give way to modern medical realities and significantly improved survivorship rates across the country.

The Five-Year Disregard Obligation

At the heart of the new Act is a strict legal obligation placed upon insurance providers offering mortgage protection policies within the Irish market. Under the provisions of the legislation, an insurer must entirely disregard an applicant's prior cancer diagnosis provided a specific timeframe has elapsed. Specifically, the applicant must have completed all active cancer treatment at least five years prior to the date of their insurance application. Furthermore, they must have remained in complete remission throughout that entire five-year period. This effectively creates a clean slate, ensuring that survivors who have reached this critical medical milestone are assessed on the exact same terms as any other applicant, without the shadow of their previous diagnosis inflating their premiums or jeopardising their mortgage approval process.

Financial Thresholds and the Housing Market

Recognising the realities of the contemporary Irish housing market, the legislation incorporates specific financial thresholds designed to cover the vast majority of standard residential purchases. The statutory disregard requirement applies to mortgage protection insurance policies up to a maximum value of six hundred and fifty thousand euros. For properties requiring cover that exceeds this prescribed maximum, insurers are permitted to apply their standard medical underwriting processes, but only to the excess amount. Crucially, the Act mandates that the Minister for Finance must review this maximum threshold at least once every five years. This periodic review will be informed by the most recent residential property price indices published by the Central Statistics Office, ensuring that the protection limits evolve in tandem with property valuations following consultation with consumer representatives and the insurance industry.

Information Requests and Underwriting Boundaries

While the legislation significantly restricts how insurers can use historical cancer data, it also establishes a clear framework for how they may verify an applicant's eligibility for this new protection. Insurance companies retain the right to submit a written notice requesting information that is reasonably necessary to process the application. In practice, this means insurers can ask for the specific dates when the cancer diagnosis was confirmed and when active treatment officially ceased. They may also require formal confirmation from a consultant oncologist verifying that the applicant has indeed been in complete remission for the requisite five years. The insurer is permitted to specify the format and timeframe for the submission of these medical details, ensuring the underwriting process remains structured and strictly evidence-based.

Transparency in Decisions and Future Outlook

The Act also introduces enhanced transparency measures regarding how insurance decisions are communicated to consumers. Whether an insurer decides to grant or refuse an application, they are legally obligated to notify the applicant in writing. In cases where cover is declined, the insurer must provide a comprehensive statement of reasons outlining exactly why the application was unsuccessful. It is also important to note that the legislation does not provide blanket immunity from all medical underwriting; insurers remain fully entitled to consider any other medical conditions that are entirely unrelated to the applicant's history of cancer. As the public awaits the formal commencement of the Act, its provisions stand as a beacon of progress, promising to end the financial discrimination faced by cancer survivors and offering them a fair, unencumbered path to securing their family homes.